Timber Pharmaceuticals Inc Asset Turnover Ratio (TMBR), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Timber Pharmaceuticals Inc   (NYSE: TMBR)
 

Timber Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2023, Timber Pharmaceuticals Inc has not recorded any assets.
Visit Timber Pharmaceuticals Inc Balance sheet

Within sector Timber Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition



TMBR Asset Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Asset Change -68.65 % -60.18 % -40.47 % 180.93 % 36.51 %
Y / Y Revenue Change - - -98.71 % - -
Asset Turnover Ratio (TTM) 0 - 0.01 - -
TMBR's Total Ranking # # # # #
Seq. Asset Change -47.8 % -44.91 % -19.66 % 35.68 % -33.7 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Foxo Technologies Inc   0.02 $ 0.457  Millions$ 30.204  Millions
Astrotech Corp  0.01 $ 0.750  Millions$ 50.318  Millions
Omega Therapeutics Inc   0.01 $ 2.604  Millions$ 175.350  Millions
Vivos Inc  0.01 $ 0.025  Millions$ 1.760  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 4.834  Millions$ 336.080  Millions
Oncternal Therapeutics Inc   0.01 $ 0.862  Millions$ 63.469  Millions
Vbi Vaccines Inc  0.01 $ 1.815  Millions$ 135.970  Millions
Q32 Bio Inc   0.01 $ 2.760  Millions$ 214.585  Millions
Mesoblast Limited  0.01 $ 7.501  Millions$ 669.415  Millions
Fulcrum Therapeutics Inc   0.01 $ 3.043  Millions$ 273.986  Millions
Lyra Therapeutics Inc   0.01 $ 1.238  Millions$ 112.244  Millions
Vyne Therapeutics Inc   0.01 $ 0.407  Millions$ 36.972  Millions
Marizyme Inc   0.01 $ 0.485  Millions$ 44.416  Millions
Spyre Therapeutics Inc   0.01 $ 1.228  Millions$ 114.673  Millions
Chinook Therapeutics Inc   0.01 $ 5.849  Millions$ 549.276  Millions
Cytokinetics Incorporated  0.01 $ 9.952  Millions$ 940.113  Millions
Pliant Therapeutics Inc   0.01 $ 5.027  Millions$ 475.142  Millions
Insight Molecular Diagnostics Inc   0.01 $ 1.053  Millions$ 106.944  Millions
Century Therapeutics inc   0.01 $ 4.564  Millions$ 467.921  Millions
Inhibikase Therapeutics Inc   0.01 $ 0.252  Millions$ 26.007  Millions
Celldex Therapeutics inc   0.01 $ 3.255  Millions$ 336.448  Millions
Synlogic Inc   0.01 $ 0.993  Millions$ 102.957  Millions
Bridgebio Pharma Inc   0.01 $ 5.675  Millions$ 620.279  Millions
Verve Therapeutics Inc   0.01 $ 5.438  Millions$ 644.021  Millions
Biorestorative Therapies Inc   0.01 $ 0.129  Millions$ 15.434  Millions
Sage Therapeutics Inc   0.01 $ 10.371  Millions$ 1,286.374  Millions
4d Molecular Therapeutics Inc   0.01 $ 2.285  Millions$ 284.634  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 11.490  Millions
Axim Biotechnologies Inc   0.01 $ 0.026  Millions$ 4.245  Millions
Traws Pharma inc   0.01 $ 0.217  Millions$ 37.170  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.